Fernando Álvarez, director general of Allergan Iberia, highlights the market’s shift towards more holistic innovation and the company’s main growth drivers, especially in the field of aesthetics. Furthermore, he touches on the importance of the market access team in the fragmented Spanish healthcare ecosystem and his ambitions for Allergan throughout the region in the future.
In today’s market, products must be more sophisticated and encompass a larger spread of requirements, not only the needs of the doctors,but equally of the system and patients
